MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris

Journal of Investigative Dermatology

Volumn 134, Issue 1, 2014, Pages 68-76

  Mao, Xuming ^a   Li, Hong ^a   Sano, Yasuyo ^b   Gaestel, Matthias ^c   Park, Jin Mo ^b   Payne, Aimee S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOGLEIN 3; DESMOGLEIN ANTIBODY; IMMUNOGLOBULIN G4; MITOGEN ACTIVATED PROTEIN KINASE 14; MK2 PROTEIN; PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ACANTHOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLISTER; CONTROLLED STUDY; CYTOSOL; ENDOCYTOSIS; ENZYME ACTIVATION; GENE DELETION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84890970477     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.224     Document Type: Article

References (32)

1. Amagai M, Ishii K, Hashimoto T et al. (1995) Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J Invest Dermatol 105: 243-7
2. Amagai M, Karpati S, Prussick R et al. (1992) Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 90: 919-26
3. Berkowitz P, Diaz LA, Hall RP et al. (2007) Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin. J Invest Dermatol 128: 738-40
4. Berkowitz P, Hu P, Liu Z et al. (2005) Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem 280: 23778-84
5. Berkowitz P, Hu P, Warren S et al. (2006) p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci USA 103: 12855-60
6. Calkins CC, Setzer SV, Jennings JM et al. (2006) Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 281: 7623-34
7. Cirillo N, Femiano F, Gombos F et al. (2006) Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett 580: 3276-81
8. Engel K, Kotlyarov A, Gaestel M (1998) Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J 17: 3363-71
9. Goldstein DM, Kuglstatter A, Lou Y et al. (2010) Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders. J Med Chem 53: 2345-53
10. Heupel WM, Zillikens D, Drenckhahn D et al. (2008) Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J Immunol 181: 1825-34
11. Jolly PS, Berkowitz P, Bektas M et al. (2010) p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem 285: 8936-41
12. Kawasaki Y, Aoyama Y, Tsunoda K et al. (2006) Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line. Autoimmunity 39: 587-90
13. Kayyali US, Pennella CM, Trujillo C et al. (2002) Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem 277: 42596-602
14. Kitajima Y (2002) Mechanisms of desmosome assembly and disassembly. Clin Exp Dermatol 27: 684-90
15. Kotlyarov A, Yannoni Y, Fritz S et al. (2002) Distinct cellular functions of MK2. Mol Cell Biol 22: 4827-35
16. Kotlyarov A, Neininger A, Schubert C et al. (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1: 94-7
17. Mao X, Choi EJ, Payne AS (2009) Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies. J Invest Dermatol 129: 908-18
18. Mao X, Sano Y, Park JM et al. (2011) p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. J Biol Chem 286: 1283-91
19. Menon MB, Schwermann J, Singh AK et al. (2010) p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins. J Biol Chem 285: 33242-51
20. Payne AS, Ishii K, Kacir S et al. (2005) Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 115: 888-99
21. Payne AS, Siegel DL, Stanley JR (2007) Targeting pemphigus autoantibodies by their heavy chain variable region genes. J Invest Dermatol 127: 1681-91
22. Ronkina N, Kotlyarov A, Dittrich-Breiholz O et al. (2007) The mitogenactivated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol Cell Biol 27: 170-81
23. Saito M, Stahley SN, Caughman CY et al. (2012) Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. PLoS One 7:e50696
24. Sanchez-Carpintero I, Espana A, Pelacho B et al. (2004) In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. Br J Dermatol 151: 565-70
25. Sharma P, Mao X, Payne AS (2007) Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus. J Dermatol Sci 48: 1-14
26. Spindler V, Endlich A, Hartlieb E et al. (2011) The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting? Am J Pathol 179: 1905-16
27. Spindler V, Rotzer V, Dehner C et al. (2013) Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering. J Clin Invest 123: 800-11
28. Stokoe D, Engel K, Campbell DG et al. (1992) Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett 313: 307-13
29. Tsunoda K, Ota T, Aoki M et al. (2003) Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 170: 2170-8
30. Waschke J, Spindler V, Bruggeman P et al. (2006) Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol 175: 721-7
31. Williamson L, Raess NA, Caldelari R et al. (2006) Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J 25: 3298-309
32. Yeh SW, Cavacini LA, Bhol KC et al. (2006) Pathogenic human monoclonal antibody against desmoglein 3. Clin Immunol 120: 68-75 Skin Diseases